These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3500481)

  • 1. The maturational onset of the 5-HT mediated head twitch in mice.
    Eble JP; Goodrich C
    Physiol Behav; 1987; 41(1):47-51. PubMed ID: 3500481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG
    Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan.
    Endo Y
    Br J Pharmacol; 1985 Jul; 85(3):591-8. PubMed ID: 3875380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of serotonin precursors on alpha- and gamma-motoneuron activity.
    Myslinski NR; Anderson EG
    J Pharmacol Exp Ther; 1978 Jan; 204(1):19-26. PubMed ID: 304098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS; Buckholtz NS; Boggan WO
    Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of pentoxifylline on 5-hydroxytryptamine in the mouse brain].
    Kitatani T; Hayashi S; Sakaguchi T
    Nihon Yakurigaku Zasshi; 1985 Nov; 86(5):353-8. PubMed ID: 2417922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
    Luscombe G; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Jun; 32(12):1857-64. PubMed ID: 6192824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
    Luscombe G; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of benzodiazepines on the 5-HT agonist-induced head-twitch response in mice.
    Moser PC; Redfern PH
    Eur J Pharmacol; 1988 Jul; 151(2):223-31. PubMed ID: 2844552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):87-90. PubMed ID: 2986413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.
    Green AR; Heal DJ; Johnson P; Laurence BE; Nimgaonkar VL
    Br J Pharmacol; 1983 Oct; 80(2):377-85. PubMed ID: 6606460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
    Ortmann R; Waldmeier PC; Radeke E; Felner A; Delini-Stula A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):185-92. PubMed ID: 6966764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion.
    Zimmermann H; Ganong WF
    Neuroendocrinology; 1980; 30(2):101-7, 109. PubMed ID: 6986577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quipazine-induced head-twitch in mice.
    Malick JB; Doren E; Barnett A
    Pharmacol Biochem Behav; 1977 Mar; 6(3):325-9. PubMed ID: 140381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptophan (5-HTP) uptake and decarboxylation in the kitten brain.
    Kitahama K; Jouvet A; Fujimiya M; Nagatsu I; Arai R
    J Neural Transm (Vienna); 2002 May; 109(5-6):683-9. PubMed ID: 12111460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of 5-hydroxy-N-acetyltryptophan, a putative synthetic precursor of N-acetylserotonin.
    Burns TG; Szechtman H; Brown GM; Snieckus V
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):359-63. PubMed ID: 6984517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone enhances head twitch behavior in mice.
    Kitamura Y; Nagatani T; Watanabe T
    Eur J Pharmacol; 1994 Mar; 253(3):297-301. PubMed ID: 8200425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat.
    Salter M; Hazelwood R; Pogson CI; Iyer R; Madge DJ; Jones HT; Cooper BR; Cox RF; Wang CM; Wiard RP
    Neuropharmacology; 1995 Feb; 34(2):217-27. PubMed ID: 7617147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to the increased locomotor activity produced by L-5-hydroxytryptophan following peripheral decarboxylase inhibition in mice.
    Magyar RL; Gillin JC; Wyatt RJ
    Psychopharmacology (Berl); 1978 Apr; 56(3):343-50. PubMed ID: 418444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.